Note: Ingredients listed on restricted chemical lists
EC/CAS
91-20-3
Name of the chemical
Naphthalene,3
Concentration
N/A
EC/CAS
872-50-4
Name of the chemical
N-Methyl-2-Pyrrolidone; 1-methyl-2-pyrrolidone (NMP)
Concentration
N/A
General Information
Revision date
2010-10-16
Product name
Ovasyn Options Insecticide
Substance name
Amitraz is an amidine based insecticide
Icons in SDS
Company Information
company name
Arysta Lifescience Corporation
Section 2
Hazard statements
This product is classified as: Hazardous according to the criteria of NOHSC Australia. This product does not meet the criteria of the Australian Dangerous Goods (ADG) Code. However, this is a C1 Combustible Liquid and for storage meets the definition of Dangerous Goods. R65, R20/21/22, R36/38. Harmful May cause lung damage if swallowed. Harmful by inhalation, in contact with skin, and if swallowed. Irritating to eyes and skin.
Precautionary statements
S20, S23, S38, S46, S24/25, S36/37/39. When using, do not eat or drink. Do not breathe vapours or spray mists. In case of insufficient ventilation, wear suitable respiratory equipment. If swallowed, contact a doctor or Poisons Information Centre immediately and show this container or label. Avoid contact with skin and eyes. Wear suitable protective clothing, gloves and eye/face protection.
SUSDP Classification
S6
ADG classification
None allocated. Not a Dangerous Good under the ADG Code
UN Number
None allocated Emergency Overview Physical Description & Colour: Clear, amber liquid. Odour: Characteristic aromatic hydrocarbon odour.
Health hazards
Signs of acute Amitraz poisoning in male and female rats treated with 440 mg/kg and 365 mg/kg respectively, include coolness to touch, reduced spontaneous activity, episodes of increased induced activity such as aggression in response to handling, and signs of general debilitation. harmful by inhalation, in contact with skin, and if swallowed, irritating to eyes and skin, if aspirated, may cause lung damage.
Potential health effects
See section 11 for Chronic exposure studies. Contact with naphthalene can cause skin photosensitivity on contacted areas. Subsequent exposure to UV alpha rays in sunlight can cause sunburn in affected area. Inhalation Short Term Exposure: Available data shows that this product is harmful, see symptoms above. Skin Contact: Short Term Exposure: Available data shows that this product is harmful, see symptoms above. In addition product is a skin irritant. Symptoms may include itchiness and reddening of contacted skin. Other symptoms may also become evident, but all should disappear once exposure has ceased. Contact with naphthalene can cause skin photosensitivity on contacted areas. Subsequent exposure to UV alpha rays in sunlight can cause sunburn in affected area. Eye Contact: Short Term Exposure: This product is an eye irritant. Symptoms may include stinging and reddening of eyes and watering which may become copious. Other symptoms may also become evident. If exposure is brief, symptoms should disappear once exposure has ceased. However, lengthy exposure or delayed treatment may cause permanent damage. Ingestion: Short Term Exposure: Significant oral exposure is considered to be unlikely. However, available data shows that this product is harmful, see symptoms above. Because of the low viscosity of this product, it may directly enter the lungs if swallowed, or if subsequently vomited. Once in the lungs, it is very difficult to remove and can cause severe injury or death. This product is unlikely to cause any irritation problems in the short or long term. Carcinogen Status: NOHSC: No significant ingredient is classified as carcinogenic by NOHSC. NTP: No significant ingredient is classified as carcinogenic by NTP. IARC: Naphthalene is classed 2b IARC - possibly carcinogenic to humans. See the IARC website for further details. A web address has not been provided as addresses frequently change.